𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors

✍ Scribed by Katia Varani; Stefania Gessi; Stefania Merighi; Fabrizio Vincenzi; Elena Cattabriga; Annalisa Benini; Karl-Norbert Klotz; Pier Giovanni Baraldi; Mojgan Aghazadeh Tabrizi; Stephen Mac Lennan; Edward Leung; Pier Andrea Borea

Book ID
113487741
Publisher
Elsevier Science
Year
2005
Tongue
English
Weight
595 KB
Volume
70
Category
Article
ISSN
0006-2952

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Characterization of potent ligands at hu
Characterization of potent ligands at human recombinant adenosine receptors
✍ Gloria Cristalli; Emidio Camaioni; Stefano Costanzi; Sauro Vittori; Rosaria Volp πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 120 KB πŸ‘ 2 views

The four adenosine receptor subtypes have been stably transfected into Chinese hamster ovary (CHO) cells allowing for comparative studies in a similar cellular background, using radioligand binding studies (A 1 , A 2A , A 3 ) or adenylyl cyclase activity assays (A 2B ). We are currently using the tr

Pharmacological characterization of AMP
Pharmacological characterization of AMP 579, a novel adenosine A1/A2 receptor agonist and cardioprotective
✍ Linda Merkel; Camilo J. Rojas; Michael F. Jarvis; Bryan F. Cox; Cynthia Fink; Gl πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 302 KB πŸ‘ 1 views

2Ξ²,3Ξ²,4Ξ±(S\*) ]-4-[7- [[1-[(3-chloro-2-thienyl)methyl]propylamino]-3Himidazo [4,5-b]pyridin-3-yl]-N-ethyl-2,3-dihydroxy cyclopentanecarboxamide) is a novel cardioprotective adenosine agonist with the following order of affinity at adenosine receptors: A 1 > A 2A > A 3 . Agonism at A 1 receptors was